EUVIMEDEUVIMED entdecken
Crossref

The Surgical Management of Intracranial Metastasis Secondary to Follicular Cell‐Derived Thyroid Carcinoma

Victoria Harries, Alana Eagan, R Michael Tuttle, Ashok R Shaha, Richard J Wong, Jatin P Shah, Snehal G Patel, Cameron Brennan, Ian Ganly

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.27883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Victoria Harries und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: This research was funded in part through the NIH/NCI Cancer Center Support Grant, P30 CA008748..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intracranial metastases (ICM) from follicular cell‐derived thyroid carcinoma (FCDTC) are rare and are associated with a poor prognosis. The objective of this study is to report our experience in the surgical management of patients with ICM secondary to FCDTC.

Methods

Patients with FCDTC who underwent surgical resection of an ICM were identified at our institution from 1998 to 2018.

Results

Thirty‐two patients were included in this study. Nineteen patients (59%) had involvement of the brain parenchyma only, 8 (25%) had a dural‐based metastasis, 3 (9%) had a calvarial metastasis with dural extension, and 2 (6%) had a skull base metastasis with dural extension. In patients who had an R0‐1 resection, the estimated lesional control at the site of resection was 91% at 3 years. However, overall ICM control was 37% at 3 years due to the progression of other ICM lesions. The 1‐year disease‐specific survival (DSS) was 87% and 5‐year DSS was 37%.

Conclusions

ICM management in FCDTC is based on the size, number, and location of metastatic lesions. Complete resection of ICM may provide lesional control at the site of resection, however, DSS is poor due to the presence of other ICMs and metastases at multiple distant sites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinoma, FollicularBrain NeoplasmsHumansFemaleMaleMiddle AgedAdultAgedRetrospective StudiesSurvival RatePrognosisFollow-Up StudiesYoung Adult

Stichwörter der Autor:innen

braindistantintracranialmetastasisthyroid cancer

Autor:innen und Institutionen

  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Förderung

  • This research was funded in part through the NIH/NCI Cancer Center Support Grant, P30 CA008748.

Zitieren

APA

Harries, V., Eagan, A., Tuttle, R. M., Shaha, A. R., Wong, R. J., Shah, J. P., Patel, S. G., Brennan, C., & Ganly, I. (2025). The Surgical Management of Intracranial Metastasis Secondary to Follicular Cell‐Derived Thyroid Carcinoma. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27883

Vancouver

Harries V, Eagan A, Tuttle RM, Shaha AR, Wong RJ, Shah JP, et al. The Surgical Management of Intracranial Metastasis Secondary to Follicular Cell‐Derived Thyroid Carcinoma. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27883

BibTeX
@article{Harries2025,
  author = {Harries, Victoria and Eagan, Alana and Tuttle, R Michael and Shaha, Ashok R and Wong, Richard J and Shah, Jatin P and Patel, Snehal G and Brennan, Cameron and Ganly, Ian},
  title = {The Surgical Management of Intracranial Metastasis Secondary to Follicular Cell‐Derived Thyroid Carcinoma},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.27883}
}
Kostenlos starten →